News
Despite the slow trickle of updates on President Donald Trump’s proposed pharmaceutical import tariffs, drugmakers have ...
Hikma Pharmaceuticals USA (HKMPF) plans to invest $1 billion through 2030 to boost its U.S. manufacturing and R&D. Read more details here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback